Talking Biotech Podcast 411
Who's paying you to talk about cool science? Probably nobody! But Twitter knows better!
Dr Chris MacDonald and I discuss the accusation, its psychology, and how to respond. @ColabraHQ @ethicsblogger https://t.co/hnzaX5SCAs
Going into Year 9! Against All Odds!
Talking Biotech 393 - A discussion of how @novartis adjusted to weave #ArtificialIntelligence into drug discovery, and exploit big data for personalized medicine. @ColabraHQ https://t.co/rZe7Q86r55
This week's Talking Biotech Podcast #390 examines the business environment of biotechnology and Big Data. How do companies adapt to a constantly changing technology environment? My guest is Jeffery Reid from @RegeneronDNA@colabraHq https://t.co/kwsPt94T3X
lking Biotech 389 - Science Controversies and #SciComm
Dr. Liza Dunn @DrLizaMD discusses some of the recent trends on Twitter, and how we can help shift hearts and minds toward evidence. @ColabraHQ@Bayer4Crops https://t.co/K2e5HEmvUL
Talking Biotech 388 - The potato is a world food staple, but it is threated by the the same disease that caused the Irish Potato Famine. Scientists have used wild potato genes to make a resistant potato for food insecure nations. @michiganstateu@colabraHQ
https://t.co/t3eOjnAJyV
Talking Biotech 382 - Chunks of plant DNA are naturally moving between species. Lateral gene transfer is remarkably common, and has huge implications for how we think about evolution, ecology and #GMO regulation. @ASPB@ashs_hort@sheffielduni https://t.co/0A0nH7Pv9o
The @AquaBountyFarms biotech salmon checks many sustainability boxes, and finally is available near you. Learn more about what it is, and how you can help address sustainability questions to increase access to this innovation. This week's podcast.
https://t.co/viXU0cALIe
The @AquaBountyFarms biotech salmon checks many sustainability boxes, and finally is available near you. Learn more about what it is, and how you can help address sustainability questions to increase access to this innovation. This week's podcast.
https://t.co/viXU0cALIe
Talking Biotech 380 - Is the key to long-term disease to first arrest biology associated with aging? Fascinating conversation with Dr. Eric Morgen of @bioagelabs about new therapeutics that might slow age-related disorders. https://t.co/nMWL2ZJ2vN
Talking Biotech 379 - In the modern noise of lab leaks and man-made viruses, how likely is it that biotech could be weaponized? Dr. Kevin Esvelt joins the podcast to discuss a dark side of molecular biology. @MIT@kesvelt https://t.co/SQAgCsl0uJ
Talking Biotech #378 - How is biotechnology used to predict disorders in the developing fetus? @UF genetic counselor Dan Weisman discusses the cutting edge of technologies that help parents and physicians make important decisions. https://t.co/1MmW0zdBDP
How can a new generation of drugs specifically target the mechanisms that control cell proliferation to arrest #cancer? This week's podcast covers novel inhibitors of the cell cycle in cancer therapy. @CyclacelPharma@ColabraHQ#MedTwitter#CancerResearch
https://t.co/Iz5a6uMVTX
Talking Biotech Podcast 372
An amazing conversation with Prof Matthew Cobb about his new book, "As Gods - A Moral History of the Genetic Age".
Just because we can, does it mean we should? -- a question in molecular biology. @matthewcobb https://t.co/qsh6a7so3s
Talking Biotech Podcast 371
Genomics of Parasites - Dr. Jessie Kissinger speaks about the extensive curation of parasite genomes and how they are being used to solve pressing problems in health and agriculture.
https://t.co/TeQxQW1Quo
Talking Biotech Podcast 370 - #Cancer#misinformation can kill. An industry thrives on fake cures, expensive nostrums and bogus claims. Dr. Skyler Johnson speaks of false cancer claims in social media. Speaking this week also at @UF@UFmedicine@UF_IFAS https://t.co/77TEKgI0sk
Malaria kills someone every 60 seconds in the Developing World. A new vaccines shows promise, using CRISPR/Cas9 to disarm the causative pathogen. This week's Talking Biotech Podcast. https://t.co/Wn0KKS4fE7
Malaria kills someone every 60 seconds in the Developing World. A new vaccines shows promise, using CRISPR/Cas9 to disarm the causative pathogen. This week's Talking Biotech Podcast. https://t.co/Wn0KKS4fE7
Neurological disorders like MS and ALS share a common theme- re-activation of ancient latent viruses in our genomes. #SARSCoV2 is shown to do the same thing, perhaps explaining the effects of #LongCovid. This week's podcast #GetVaccinated#COVID19 https://t.co/40vLBMTYMt